This Clorox Analyst Believes There Is Downside To Estimates
Portfolio Pulse from Priya Nigam
Goldman Sachs analyst Bonnie Herzog reiterated a Sell rating for Clorox Co (NYSE:CLX) with a price target of $132, citing negative risk/reward ahead of its quarterly earnings. Despite progress in product availability, challenges remain due to competition and promotional needs. Herzog sees downside to current estimates and expects organic sales growth to be back-end loaded in fiscal 2025.
October 08, 2024 | 2:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs analyst Bonnie Herzog reiterated a Sell rating for Clorox Co (NYSE:CLX) with a price target of $132, citing negative risk/reward ahead of its quarterly earnings. Despite progress in product availability, challenges remain due to competition and promotional needs. Herzog sees downside to current estimates and expects organic sales growth to be back-end loaded in fiscal 2025.
The analyst's Sell rating and price target of $132 suggest a negative outlook for Clorox's stock price. The mention of challenges in product availability, competition, and promotional needs indicates potential headwinds for the company. The expectation of downside to current estimates and back-end loaded sales growth further supports a negative short-term impact.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100